Latest filing published 03 Dec 2025 for Vir Biotechnology, Inc., €989k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +167.9%Entry US$13.66 · Close at T+365 US$36.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
SVF Endurance (Cayman) Ltd: trading record in brief
SVF Endurance (Cayman) Ltd appears in our data through filings on Vir Biotechnology, Inc. shares, published by SEC (Form 4). The record holds 115 filings, for trades running from 16 October 2019 to 1 December 2025.
The open-market side counts 1 purchase for €17.2M alongside 113 sales for €138.3M. Sales outweigh purchases by €121.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings no purchases and 11 sales.
Most recently, on 3 December 2025, the filings show an open-market sale worth €989k in Vir Biotechnology, Inc. The clock since the last published purchase (17 October 2019) now reads 2,579 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to SVF Endurance (Cayman) Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 191,854 shares@ US$5.98261.4% of flowCommon StockSEC:0001493152-25-025970:0
- 127,938 shares@ US$6.3911.0% of flowCommon StockSEC:0001493152-25-025571:0
- 227,803 shares@ US$6.14911.7% of flowCommon StockSEC:0001493152-25-025161:0
- 24,453 shares@ US$6.50250.2% of flowCommon StockSEC:0001493152-25-020240:0
- 46,696 shares@ US$5.95950.3% of flowCommon StockSEC:0001493152-25-019892:0
- 144,266 shares@ US$6.15291.1% of flowCommon StockSEC:0001493152-25-019309:0
- 220,535 shares@ US$6.19981.7% of flowCommon StockSEC:0001493152-25-018917:0
- 16,671 shares@ US$6.07020.1% of flowCommon StockSEC:0001493152-25-018462:0
- 249,060 shares@ US$6.14281.9% of flowCommon StockSEC:0001493152-25-018021:0
- 72,133 shares@ US$5.60290.5% of flowCommon StockSEC:0001493152-25-017612:0
- 450,342 shares@ US$5.55533.0% of flowCommon StockSEC:0001493152-25-017300:0
- 700 shares@ US$25.110.0% of flowCommon StockSEC:0000899243-23-017010:0
- 7,010 shares@ US$25.09580.2% of flowCommon StockSEC:0000899243-23-016775:0
- 9,902 shares@ US$25.17690.3% of flowCommon StockSEC:0000899243-23-016308:0
- 52,765 shares@ US$25.84651.8% of flowCommon StockSEC:0000899243-23-016075:0
- 36,547 shares@ US$26.80581.3% of flowCommon StockSEC:0000899243-23-015663:0
- 34,365 shares@ US$27.31651.2% of flowCommon StockSEC:0000899243-23-014628:0
- 2,317 shares@ US$25.83850.1% of flowCommon StockSEC:0000899243-23-013936:0
- 91,651 shares@ US$25.38143.0% of flowCommon StockSEC:0000899243-23-013759:0
- 136 shares@ US$25.10320.0% of flowCommon StockSEC:0000899243-23-012478:0
- 83,674 shares@ US$25.5122.7% of flowCommon StockSEC:0000899243-23-012410:0
- 3,075 shares@ US$25.30470.1% of flowCommon StockSEC:0000899243-23-012176:0
- 66,038 shares@ US$25.41922.1% of flowCommon StockSEC:0000899243-23-011791:0
- 6,590 shares@ US$25.06030.2% of flowCommon StockSEC:0000899243-23-011617:0
- 6,953 shares@ US$25.12030.2% of flowCommon StockSEC:0000899243-23-011512:0
25 of 115 declarations
